How Opening Up Fuels Growth in the Chinese Mainland’s 14th Five-Year Plan
As the Chinese mainland wraps up its 14th Five-Year Plan, learn how broader, high-standard opening up has driven domestic and global growth and set the stage for 2026-2030.
Politics
Get the latest on G20 policies, global diplomacy, and key political developments.
Brazil Files WTO Case Over U.S. 50% Tariffs
Brazil files a WTO request challenging U.S.’s 50% tariffs on its goods, calling for consultations to resolve the trade dispute.
Trump-Putin Summit in Coming Days: A Pivotal Moment for Ukraine
A high-stakes Trump-Putin meeting is set in the coming days, marking a new chapter in the Ukraine conflict and global diplomacy.
UN Warns Gaza Food Crisis as Only 1.5% Farmland Usable
UN: Gaza crisis ‘beyond catastrophic’ as only 1.5% farmland remains usable, driving the territory toward famine amid rising casualties.
Inside China’s 14th Five-Year Plan: A Blueprint for High-Quality Growth
China’s 14th Five-Year Plan shifts from growth to high-quality development, driving sustainability, tech breakthroughs and global stability as 2021–2025 wraps up.
Aramco CEO Nasser Touts Chinese Mainland as Key Growth Market
Aramco CEO Amin H. Nasser highlights the Chinese mainland as a cornerstone market, unveiling a pipeline of refining and petrochemical investments.
Majority of Americans Favor Cooperation with China, Poll Finds
A new Third Way poll reveals most Americans now favor cooperation with China, with pro-trade views rising eight points and ‘enemy’ labels falling seven points since 2023.
Netanyahu’s Gaza Strategy: Annexation on the Table
Netanyahu meets top security officials to discuss Gaza annexation amid escalating humanitarian crisis, with aid trucks under fire and truce talks collapsed.
EU Suspends €93B US Tariffs Amid Member Dissent
The EU has formally suspended its planned €93 billion retaliatory tariffs on US goods for six months, opening a new chapter in transatlantic trade talks.
Trump Proposes 250% Pharma Tariffs, Teases Chip Duties
Trump plans small pharma tariffs rising to 250% and teases chip duties. What could this mean for global trade and innovation?